Awareness of disease and symptoms is essential for screening, detection and reimbursement for appropriate therapies 

On one hand—if members of the public are aware of a disease and its symptoms, they are more likely to take action to prevent it happening to them, or go to healthcare providers for check-ups.

Payers and insurers not familiar with a disease are less likely to cover them.

If a product’s value is demonstrated in a smaller patient population, they may put utilization programs in place to restrict product use.

On the other hand, if people are not aware of diseases and healthcare options it keeps them from taking preventative action or from visiting their doctor and accessing care, and may keep payers and insurers from covering treatments.